Takeuchi, Y., Nouso, K., Fujioka, S., Kariyama, K., Kobashi, H., Uematsu, S., . . . Takaki, A. (2023, September). The prediction of early progressive disease in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab. Cancer Medicine.
Chicago Style (17th ed.) CitationTakeuchi, Yasuto, et al. "The Prediction of Early Progressive Disease in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab." Cancer Medicine Sep. 2023.
MLA (9th ed.) CitationTakeuchi, Yasuto, et al. "The Prediction of Early Progressive Disease in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab." Cancer Medicine, Sep. 2023.
Warning: These citations may not always be 100% accurate.
